Compare iShares Russell 2000 ETF (IWM) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Russell 2000 ETF vs Tempus AI — how do they compare? iShares Russell 2000 ETF trades at $278.83 (market cap $78.56B), while Tempus AI trades at $70.22 (market cap $12.77B). The key difference: iShares Russell 2000 ETF is far larger — about 6.2× Tempus AI's market cap, and iShares Russell 2000 ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Russell 2000 ETF for 83 Days and Tempus AI for 22 Days on average.
| IWM | TEM | |
|---|---|---|
Market Cap | $78.56B | $12.77B |
Volume | 24,585,463 | 8,980,490 |
52-Week High | $305.06 | $99.28 |
52-Week Low | $229.13 | $41.55 |
Typical Hold Time | 83 Days | 22 Days |
Sector | — | Broad Market / Factor |
Enterprise Value | — | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IWM trades at $277.72, down 1.27% with bearish technical signals from moving averages and key indicators. The ETF faces headwinds from Federal Reserve rate hikes and underperformance relative to large-cap indices. Recent news highlights IWM's decade-long trailing of the S&P 500 while carrying higher risk, with institutional selling pressure emerging.
The outlook remains challenging as small-caps face tightening financial conditions and energy price pressures. Investment opportunity exists for long-term value investors seeking diversification from tech-heavy large-caps, though near-term risks include continued Fed hawkishness and weak small-cap breadth in the current market environment.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares Russell 2000 ETF
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
